Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans-Reference-Cited by-同舟云学术

Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans

Published:2010-08 Issue:8 Volume:50 Page:929-940
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Man Michael,Farmen Mark,Dumaual Carmen,Teng Choo Hua,Moser Brian,Irie Shin,Noh Gyu Jeong,Njau Reuben,Close Sandra,Wise Stephen,Hockett Richard

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference87 articles.

1. Genetic basis of toxic reactions to drugs and chemicals;Cascorbi;Toxicol Lett.,2006

2. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications;Dervieux;Mutat Res.,2005

3. Genetically determined differences in drug metabolism as a risk factor in drug toxicity;Eichelbaum;Toxicol Lett.,1992

4. Pharmacogenomics: drug disposition, drug targets, and side effects;Evans;N Engl J Med.,2003

5. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects;Ingelman-Sundberg;Pharmacol Ther.,2007

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open‐label study to explore the optimal design of CYP3A drug–drug interaction clinical trials in healthy Chinese people;Pharmacology Research & Perspectives;2024-07-28

2. Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier;Drug Metabolism Reviews;2024-07-05

3. The impact of CYP2C19 genotypes on steady-state plasma concentration of escitalopram in South Indian population with Major Depressive Disorder;Pharmacia;2024-05-21

4. Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial;Neurology and Therapy;2024-04-06

5. Exploring the impact of ethnicity on drug pharmacokinetics using PBPK models: A case study with lansoprazole in Japanese subjects;British Journal of Clinical Pharmacology;2024-01-16